Skip to main content
Log in

Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Human neutrophils were demonstrated to possess interleukin-2 receptor (IL-2R)β andγ chains, notα chain and the binding of IL-2 to the IL-2Rβ chain on neutrophils plays an important regulatory role in neutrophil functions. We have investigated in this study the hypothesis that recombinant human IL-2(rhIL-2) can directly activate human neutrophils and increase their adherence to human umbilical vein endothelial cells (HUVEC). In an in vitro microtiter adherence assay, rhIL-2 significantly stimulated neutrophil adherence to HUVEC in a dose- and time-dependent manner. rhILI-2 concentration at 2000 u/ml and 2 hour incubation gave the best neutrophil stimulation. Treatment of neutrophils with rhIL-2 increased the expression of adhesion molecule CD18. Pretreatment of the stimulated neutrophils with a blocking monoclonal antibody to CD18 decreased but not completely blocked the adherence of neutrophils to HUVEC. These data suggest that rhIL-2 can directly stimulate and increase neutrophil adherence to HUVEC by enhancing the expression of CD18 and possibly other adhesion molecules on neutrophil surface. This may be a critical step in the early stage of the vascular leak syndrome (VLS) associated with high dose IL-2 therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rosenberg, S. A., M. T. Lotze, L. M. Muul, A. E. Chang, F. P. Avis, S. Leitman, W. M. Linehan, C. N. Robertson, R. E. Lee, J. T. Rubin, C. A. Seipp, C. G. Simpson, andD. E. White. 1987. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2, or high-dose interleukin-2 alone.N. Engl. J. Med. 316:889.

    Google Scholar 

  2. Fisher, R. J., C. A. Coltman, andJ. H. Doroshow. 1989. Metastatic renal cell cancer treated with Interleukin-2 and lymphokine activated killer cells.Ann. Intern. Med. 108:518.

    Google Scholar 

  3. West, W. W., K. W. Tauer, J. R. Yannell, G. D. Marshall, D. W. Orr, G. B. Thurman, andR. K. Oldham. 1987. Constant infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.N. Engl. J. Med. 316:898.

    Google Scholar 

  4. Kotasek, D., G. M. Vercellotti, A. C. Ochoa, F. H. Bach, J. G. White, andH. S. Jacob. 1988. Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells.Cancer Res. 48:5528.

    Google Scholar 

  5. Cotran, R. S., J. S. Pober, M. A. Gimbrone, T. A. Springer, E. A. Wiebke, A. A. Gaspari, andS. A. Rosenberg. 1987. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.J. Immunol. 139:1883.

    Google Scholar 

  6. Ognibene, F. P., S. A. Rosenberg, andM. T. Lotze. 1988. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.Chest 94:750.

    Google Scholar 

  7. Ferrante, A. 1992. Activation of neutrophils by interleukin-1 and -2 and tumor necrosis factors.Immunology Series 57:417.

    Google Scholar 

  8. Edamitsu, S., A. Matsukawa, S. Ohkawara, K. Takagi, H. Nariuchi, andM. Yoshinaga. 1995. Role of TNFα, IL-1, and IL-1ra in the mediation of Leucocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy.Clin. Immunol. Immunopathol. 75:68.

    Google Scholar 

  9. Solomkin, J. B., B. C. Bass, H. S. Bjornson, C. J. Tindal, andG. F. Babcock. 1990. Alterations of neutrophils responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia.Infection and Immunity 62:943.

    Google Scholar 

  10. Moore, F. D. Jr.,D. D. Schoof, M. Rodrick, andT. J. Eberlein. 1991. The systemic complement activation caused by interleukin-2/lymphokine-activated killer-cell therapy of cancer caused minimal systemic neutrophil activation.Int. J. Cancer 49:504.

    Google Scholar 

  11. Baars, J. W., C. E. Hack, J. Wagstaff, A. J. M. Eerenberg-Belmer, G. J. Wolbink, L. G. Thus, R. J. M. Strack van Schijndel, H. L. J. A. Van Der Vall, andH. M. Pinedo. 1990. The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.Br. J. Cancer 64:96.

    Google Scholar 

  12. Ohkubo, C., D. Bigos, andR. K. Jain. 1991. Interleukin-2 induced leucocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome.Cancer Res. 51:1561.

    Google Scholar 

  13. Edwards, M. J., F. N. Miller, D. E. Sims, D. L. Abney, D. A. Schuschke, andT. S. Corey. 1992. Interleukin 2 acutely induces platelet and neutrophil-endothelial adherence and macromolecular leakage.Cancer Res. 52:3425.

    Google Scholar 

  14. Stevens, J. H., P. O'Hanley, andJ. M. Shapiro. 1986. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.J. Clin. Invest. 177:1812.

    Google Scholar 

  15. Wei, S., D. K. Blanchard, J. H. Liu, W. J. Leonard, J. Y. Djeu. 1993. Activation of tumor necrosis factor-alpha production from human neutrophils by IL-2 via IL-2-R beta.J. Immunol. 150:1979.

    Google Scholar 

  16. Mullen, P. G., A. C. J. Windsor, C. J. Walsh, A. A. Fowler, andH. J. Sugerman. 1995. Tumor necrosis factor-α and interleukin-6 selectively regulate neutrophil function in vivo.J. Surg. Res. 58:124.

    Google Scholar 

  17. Djeu, J. Y., J. H. Liu, S. Wei, H. Rui, C. A. Pearson, W. J. Leonard, andD. K. Blanchard. 1993. Function associated with IL-2 receptor-β on human neutrophils: Mechanism of activation of antifungal activity against candida albicans by IL-2.J. Immunol. 150:960.

    Google Scholar 

  18. Liu, J. H., S. Wei, D. Ussery, P. K. Epling-Burnette, W. J. Leonard, andJ. Y. Djeu. 1994. Expression of interleukin-2 receptory chain on human neutrophils.Blood 84:3870.

    Google Scholar 

  19. Dorfman, R. F., K. C. Gatter, K. A. F. Pulford, andD. Y. Mason. 1986. An evaluation of the utility of anti-granulocyte and anti-leucocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.Am. J. Pathol. 123:508.

    Google Scholar 

  20. Ohashi, Y., T. Takeshita, K. Nagata, S. Mori, andK. Sugamura. 1989. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.J. Immunol. 143:3548.

    Google Scholar 

  21. Kovach, N. L., C. G. Lindgren, A. Fefer, J. A. Thompson, T. Yednock, andJ. M. Harlan. 1994. Pentoxifylline inhibits integrin-mediated adherence of interleukin-2 activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells.Blood 84:2234.

    Google Scholar 

  22. Brunson, K. W., M. Ohashi, C. A. Miller, R. P. Kitson, P. H. Basse, andR. H. Goldfarb. 1994. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.In Vivo 8:71.

    Google Scholar 

  23. Frasier-Scott, K., H. Hatzakis, D. Seong, C. M. Jones, andK. K. Wu. 1988. Influence of natural and recombinant interleukin 2 on endothelial cell arachidonatic metabolism. Induction of de novo synthesis of prostaglandin H synthesis.J. Clin. Invest. 82:1877.

    Google Scholar 

  24. Mier, J. W., G. Vachino, J. W. M. Van Der Meer, R. P. Numerof, S. Adams, J. G. Cannon, H. A. Bernheim, M. B. Atkins, D. R. Parkinson, andC. A. Dinarello. 1988. Induction of circulation tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.J. Clin. Immunol. 8:426.

    Google Scholar 

  25. Gusella, G. L., T. Musso, M. C. Bosco, I. Espinoza-Delgado, K. Matsushima, andL. Varesio. 1993. IL-2 up-regulation but IFN-γ suppressed IL-8 expression in human monocytes.J. Immunol. 151:2725.

    Google Scholar 

  26. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, andD. Anderson. 1994. Utilization of theβ andγ chains of the IL-2 receptor by the novel cytokine IL-15.J. EMBO 13:2822.

    Google Scholar 

  27. Grant, A. J., E. Roessler, G. Ju, M. Tsudo, K. Sugamura, andT. A. Waldmann. 1992. The interleukin 2 receptor (IL-2): The IL-2Rα subunit alters the function of the IL-2Rβ subunit to enhance IL-2 binding and signalling by mechanisms that do not require binding of IL-2 to IL-2R α subunit.Proc. Natl. Acad. Sci. U.S.A. 89:2165.

    Google Scholar 

  28. Suzuki, H., T. M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohashi, H. Griesser, T. Taniguchi, andC. J. Paige. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptorβ. Science268:1472.

    Google Scholar 

  29. Ishii, N., T. Takeshita, Y. Kimura, K. Tada, M. Kondo, M. Nakamura, andK. Sugamura. 1994. Expression of the IL-2 receptorγ chain on various populations in human peripheral blood.Int. Immunol. 6:1273.

    Google Scholar 

  30. Price, T. H., P. G.Beatty, and S. R.Corpuz. 187. In vivo inhibition of neutrophil function in the rabbit using monoclonal antibody to CD18.J. Immunol. 139:4174.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Gyorffy, S., Lee, S. et al. Effect of recombinant human interleukin 2 on neutrophil adherence to endothelial cells in vitro. Inflammation 20, 361–372 (1996). https://doi.org/10.1007/BF01486739

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01486739

Keywords

Navigation